NCT00495378 RAPID-2. A Study to Evaluate the Effectiveness of Alternate Dosing of PROCRIT (Epoetin Alfa) in Maintaining Hemoglobin Levels in Patients With Chemotherapy Related Anemia Status TERMINATED Phase PHASE4
NCT00493818 Open-label Study to Investigate the Safety, Tolerability, PK, and Pharmacodynamics of the AKT Inhibitor GSK690693 Status TERMINATED Phase PHASE1
NCT00492830 Phase 1, Open-label, Dose Escalation Study of TRC093, in Patients With Locally Advanced or Metastatic Solid Tumors Status COMPLETED Phase PHASE1
NCT00492388 Safety and Efficacy of PMI-150 (Intranasal Ketamine) for the Treatment of Breakthrough Pain in Cancer Patients Status TERMINATED Phase PHASE3
NCT00491946 A Pharmacokinetic Study of Actinomycin-D and Vincristine in Children With Cancer Status UNKNOWN Phase PHASE4
NCT00486135 Study of the Safety and Pharmacokinetics of XL147 (SAR245408) in Adults With Solid Tumors or Lymphoma Status COMPLETED Phase PHASE1
NCT00485719 Study of the Safety and Pharmacokinetics of XL765 (SAR245409) in Adults With Solid Tumors Status COMPLETED Phase PHASE1
NCT00481637 Study to Evaluate Immune Responses in Neurologically Normal Cancer Patients Status COMPLETED Phase N/A
NCT00479583 Combination Trial of BMS-690514 in Combination With FOLFIRI and FOLFOX Status COMPLETED Phase PHASE1
NCT00475917 A Study of XL844 Administered as a Single Agent and in Combination With Gemcitabine in Adults With Advanced Malignancies Status TERMINATED Phase PHASE1
NCT00473616 Phase I Single Ascending Dose/Multiple Ascending Dose in Patients Treated With AZD7762 and Irinotecan Status TERMINATED Phase PHASE1
NCT00463814 AZD6244 (ARRY-142886) Solid Oral Dosage Formulation in Participants With Advanced Solid Malignancies Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT00463060 Sutent and Radiation as Treatment for Limited Extent Metastatic Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00459823 A Dose Escalation Study of E7107 Administered IV (Bolus) on Days 1, 8, and 15 Every 28 Days to Patients With Solid Tumours Status SUSPENDED Phase PHASE1